Physician profile
Robert Holladay
NPI 1124023668
$22,351.11
in general payments reported to CMS, 2019-2025
63 companies · $4,637 in 2025
The $4,637 reported for 2025 was more than what 88% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,941 · 2020: $2,702 · 2021: $1,522 · 2022: $4,206 · 2023: $2,252 · 2024: $2,091 · 2025: $4,637.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,570 · Travel and Lodging: $1,920 · Consulting Fee: $400 · Education: $89.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,570.21 |
| Travel and Lodging | $1,920.03 |
| Consulting Fee | $400.00 |
| Education | $89.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,972.89 | 2021-2025 | Da Vinci Surgical System |
| Pinnacle Biologics, INC | $4,077.41 | 2019-2025 | Photofrin |
| Glaxosmithkline, LLC. | $1,938.58 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $1,758.18 | 2019-2025 | Fasenra, Tezspire, Airsupra |
| Actelion Pharmaceuticals US, INC. | $1,618.52 | 2019-2025 | Opsumit, Uptravi, Opsynvi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $1,009.13 | 2019-2025 | Ofev, Jascayd |
| Olympus Corporation of The Americas | $968.81 | 2019 | |
| Merck Sharp & Dohme LLC | $588.56 | 2019-2025 | Zerbaxa, Recarbrio, Dificid |
| Insmed, INC. | $536.27 | 2020-2025 | Arikayce, Brinsupri |
| Janssen Pharmaceuticals, INC | $479.40 | 2019-2024 | Xarelto |
| Pulmonx Corporation | $400.00 | 2023 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Chartis Catheter |
| Grifols USA, LLC | $309.45 | 2019-2025 | Prolastin-C Liquid, Xembify |
| Takeda Pharmaceuticals U.S.A., INC. | $299.28 | 2023-2025 | Glassia |
| Veran Medical Technologies, INC. | $296.93 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $248.35 | 2021-2025 | Dupixent, Libtayo |
Show all 62 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $218.17 | 2023-2025 | Illumisite |
| Olympus America INC. | $187.64 | 2023-2024 | Spiration Valve System |
| Amgen INC. | $185.43 | 2022-2025 | Tezspire |
| Verona Pharma, INC. | $146.31 | 2025 | Ohtuvayre |
| Alexion Pharmaceuticals, INC. | $143.21 | 2021-2025 | Ultomiris, Soliris |
| Novartis Pharmaceuticals Corporation | $137.96 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $133.22 | 2019-2022 | |
| Genentech USA, INC. | $131.44 | 2022-2025 | Xolair, Tecentriq |
| Inogen, INC. | $96.11 | 2023-2025 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Merit Medical Systems INC | $95.03 | 2022 | |
| Shionogi INC | $82.32 | 2020-2022 | |
| Kaleo, INC. | $78.17 | 2021-2022 | |
| Genzyme Corporation | $77.34 | 2022-2025 | |
| Leo Pharma INC. | $74.60 | 2023 | Adbry |
| Mallinckrodt Hospital Products INC. | $70.62 | 2025 | Terlivaz, Acthar |
| Mylan Specialty L.P. | $60.38 | 2019-2024 | Yupelri |
| Gyrus Acmi, INC. | $59.58 | 2025 | Spiration Valve System |
| Sanofi-Aventis U.S. LLC | $59.56 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $57.54 | 2022-2023 | |
| Gilead Sciences, INC. | $47.80 | 2019-2021 | |
| Philips North America LLC | $44.99 | 2019-2025 | Vest Therapy Und |
| Teva Pharmaceuticals USA, INC. | $44.26 | 2021 | |
| Covidien LP | $43.98 | 2019 | |
| Pentax of America, INC. | $43.22 | 2022 | |
| Baxter Healthcare | $42.68 | 2021 | |
| Inspire Medical Systems, INC. | $36.99 | 2025 | Inspire |
| La Jolla Pharmaceutical Company | $35.57 | 2024-2025 | Zevtera, Giapreza |
| Pfizer INC. | $35.43 | 2021-2024 | |
| Blueprint Medicines Corporation | $31.66 | 2023 | Ayvakit |
| Electromed, INC. | $30.02 | 2024 | Smartvest |
| Tempus Ai, INC | $28.63 | 2025 | Xt Cdx |
| Jazz Pharmaceuticals INC. | $25.79 | 2024 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $24.83 | 2019 | |
| Abbvie INC. | $24.58 | 2025 | |
| Itamar Medical INC | $22.43 | 2024 | Watchpatone |
| Sandoz INC. | $22.19 | 2019 | |
| Pharming Healthcare, INC. | $20.97 | 2019 | |
| Resmed Corp | $20.45 | 2019 | |
| Sunovion Pharmaceuticals INC. | $19.00 | 2021 | |
| Cook Medical LLC | $17.48 | 2019 | |
| Paratek Pharmaceuticals, INC. | $17.34 | 2024 | Nuzyra |
| Regeneron Pharmaceuticals, INC. | $15.15 | 2025 | Libtayo |
| Emd Serono, INC. | $13.49 | 2025 | |
| Aytu Biopharma, INC. | $13.27 | 2020 | |
| Erbe USA INC | $12.00 | 2021 | |
| Shire North American Group INC | $11.34 | 2019 | |
| Janssen Biotech, INC. | $9.18 | 2025 | Rybrevant |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Holladay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.